Kwangdong Pharmaceutical Launches 'ChondroPower 1200 Oral Gel' to Help Alleviate Degenerative Arthritis Symptoms
Kwangdong Pharmaceutical announced on June 11 that it has launched "ChondroPower 1200 Oral Gel," a non-prescription medication designed to help alleviate symptoms of degenerative arthritis.
Product image of Kwangdong Pharmaceutical's 'ChondroPower1200 Oral Gel'. Kwangdong Pharmaceutical
View original imageChondroPower 1200 Oral Gel contains 1,200 mg per dose of chondroitin sulfate sodium (hereafter referred to as chondroitin), an ingredient derived from bovine cartilage that has a structure similar to human cartilage—the highest single-dose content available in Korea. It is effective in treating mild to moderate degenerative arthritis, and the addition of xylitol, a natural sweetener, provides a mild sweetness that increases patient compliance with the medication.
Additionally, as a fast-absorbing oral gel formulation, it can be easily taken without water, making it convenient for elderly patients who may have difficulty swallowing tablets. According to an SCIE-grade study on chondroitin preparations, a once-daily oral gel (1,200 mg) offers greater dosing convenience and more rapid pain relief for degenerative arthritis compared to three daily capsules (400 mg each). The gel type formulation was shown to reduce symptoms by 24% after 14 days of administration, and by 50% from day 91, with the relief effect maintained thereafter.
ChondroPower 1200 Oral Gel is intended to be taken once daily, with packaging options of 10, 30, or 60 sachets, allowing users to select based on their desired duration of use. As a non-prescription medication, it is available for purchase at pharmacies without a prescription.
Hot Picks Today
"The Sooner You Start, the Better: Millennials & Gen Z Should Gradually Move Stock Gains 'Here' [Retirement Pension Investment Strategy] ⑧"
- [Breaking] Iran: "Complete Closure of the Strait of Hormuz... Will Attack All Ships Attempting Passage"
- "When Should I Sell My $30 Million in Shares?"... SpaceX Employees Face a Happy Dilemma
- The Game Has Changed: Investors Take Notice... "Now It's About Financial Muscle, Not Just Technology" Shaking Up Capital Markets [Click e-Industry]
- "Japan Outraged Over Korea's 'Theft'; New Variety Rights Protection Agency to Launch in August"
A representative from Kwangdong Pharmaceutical stated, "Because it is important to consistently manage joint health from the early stages, we focused on improving dosing convenience and reducing the burden of taking the medication. We hope this new product will benefit middle-aged and older adults who frequently use their joints during activities such as exercise or hiking, or who experience discomfort when climbing stairs."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.